Our Portfolio Companies

Cancer Innovate works with a growing portfolio of pioneering companies developing breakthrough technologies in healthcare, diagnostics, and patient support. These organisations are at the forefront of innovation, helping to shape the future of cancer detection, treatment, and care.

A medical technology company pioneering facial medical recognition solutions that redefine how clinicians detect and monitor facial diseases using photonics and AI.

PoC

Is at the forefront of next-generation medical diagnostics, harnessing advanced technologies and artificial intelligence (AI). Virosens Rapid is the world’s smallest electro chemical spectrometer analytical instrument designed as a digital PCR system to complement existing PCR tests.

PoC

Advanced patient remote monitoring technology for continuous transmission of patient data to clinicians for immediate access to vital health information, supporting faster decision making and earlier intervention.

Launch Ready

The next generation photonic technologies focused on early, non‑invasive detection of cancer and oral diseases.

PoC

Developing a new generation of clinically informed skincare formulations designed to prevent and repair treatment related skin damage, irritation and dryness and resilience comfort for people undergoing and recovering from cancer therapy.

Launch Ready

SENZORIN develops space-grade quantum biochips for next-generation medical diagnostics, enabling faster, more accurate disease detection through advanced Lab-on-a-Chip technology.

PoC

MediBreathe develops non‑invasive screening technology, delivered in a portable handheld device, which will be able to detect internal viral conditions and selected cancers.

PoC